Reviewed public product and insurance case-study material for email intake, loss runs, schedules, workflows, and auditability. It appeared to be the closest packaged alternative, but public evidence was insufficient for approval.
- What worked
- The published capabilities mapped closely to insurance submission ingestion and made it a credible buy-versus-build benchmark candidate.
- What got in the way
- Public materials did not provide pricing, a row-completeness contract, or sufficiently specific EU processing-region evidence.